Recent positive lab confirmation of Smart mRNA functionality is a tremendous milestone for the Company. This marks a ...

Clinical studies suggest that the mRNA vaccine could aid in treating pancreatic cancer, one of the most lethal forms of ...

Clinical studies suggest that the mRNA vaccine may play a role in treating pancreatic cancer, identified as one of the most ...

Memorial Sloan Kettering Cancer Center researchers have found RNA neoantigen vaccines that generate long-lived, functional ...

Vaccines to treat cancers have been around since 2010, the first being approved for prostate cancer, and another in 2015 for ...

Results from a trial of an mRNA vaccine for pancreatic cancer have shown that the vaccine reduces the chance of the cancer ...

Pancreatic cancer is the 10th deadliest form of cancer in the United States, according to the National Cancer Institute.

Learn more about whether Insmed Incorporated or Moderna, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

In a small trial, nearly half of pancreatic cancer patients who received an mRNA vaccine for the disease had no relapse three ...

A promising new mRNA-based vaccine for pancreatic cancer has shown potential in reducing the recurrence of the disease ...

The mRNA vaccine works by targeting genetic mutations found in pancreatic cancer, alerting the immune system to recognize and ...